Literature DB >> 28891394

The Role of Chemokines in Thyroid Carcinoma.

Sharinie Yapa1, Omar Mulla1, Victoria Green2, James England1, John Greenman2.   

Abstract

The global incidence of thyroid cancer is increasing, and metastatic spread to the lymph nodes is common in papillary thyroid carcinoma. The metastatic course of thyroid carcinoma is an intricate process involving invasion, angiogenesis, cell trafficking, extravasation, organ specific homing, and growth. A key aspect in this process involves a multitude of interactions between chemokines and their receptors. Chemokines are a group of small proteins, which act to elicit normal physiologic and immune responses principally through recruitment of specific cell populations to the site of infection or malignancy. Thyroid cancer cells, like other tumors, possess the ability to corrupt the chemokine system to their advantage by altering cell movement into the tumor microenvironment and affecting all aspects of thyroid cancer progression.

Entities:  

Keywords:  chemokine; inflammation; leukocytes; metastasis; thyroid carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28891394     DOI: 10.1089/thy.2016.0660

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  17 in total

1.  Papillary thyroid carcinoma behavior: clues in the tumor microenvironment.

Authors:  Kensey Bergdorf; Donna C Ferguson; Mitra Mehrad; Kim Ely; Thomas Stricker; Vivian L Weiss
Journal:  Endocr Relat Cancer       Date:  2019-06       Impact factor: 5.678

2.  [Three-dimensional reconstruction of cervical CT vs ultrasound for estimating residual thyroid volume].

Authors:  Hongjuan Wang; Fei Chen; Yongquan Zhang; Zhichao Li; Ying Wang; Qiang Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-03-30

Review 3.  Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer.

Authors:  Qi Liu; Wei Sun; Hao Zhang
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

4.  Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.

Authors:  Yuepeng Zhang; Yueli Tian
Journal:  BMC Endocr Disord       Date:  2022-10-20       Impact factor: 3.263

5.  Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma.

Authors:  Minjia Lu; Xingyu Xu; Baohang Xi; Qi Dai; Chenli Li; Li Su; Xiaonan Zhou; Min Tang; Yuhua Yao; Jialiang Yang
Journal:  Genes (Basel)       Date:  2018-01-19       Impact factor: 4.096

Review 6.  Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?

Authors:  Mario Rotondi; Francesca Coperchini; Francesco Latrofa; Luca Chiovato
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-21       Impact factor: 5.555

7.  Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells.

Authors:  Hongxia Shang; Junyu Zhao; Jinming Yao; Huanjun Wang; Shengnan Wang; Jianjun Dong; Lin Liao
Journal:  Thorac Cancer       Date:  2019-10-21       Impact factor: 3.500

8.  Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.

Authors:  Pedro Marques; Sayka Barry; Eivind Carlsen; David Collier; Amy Ronaldson; Sherine Awad; Neil Dorward; Joan Grieve; Nigel Mendoza; Samiul Muquit; Ashley B Grossman; Frances Balkwill; Márta Korbonits
Journal:  Acta Neuropathol Commun       Date:  2019-11-08       Impact factor: 7.801

9.  Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.

Authors:  Peng Lin; Yi-Nan Guo; Lin Shi; Xiao-Jiao Li; Hong Yang; Yun He; Qing Li; Yi-Wu Dang; Kang-Lai Wei; Gang Chen
Journal:  Aging (Albany NY)       Date:  2019-01-20       Impact factor: 5.682

10.  Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model.

Authors:  Motoyasu Saji; Caroline S Kim; Chaojie Wang; Xiaoli Zhang; Tilak Khanal; Kevin Coombes; Krista La Perle; Sheue-Yann Cheng; Philip N Tsichlis; Matthew D Ringel
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.